RUNX1 and precursor B-cell acute lymphoblastic leukemia: ETV6-RUNX1 accounts for 25% of pediatric B-ALL cases (Wray et al., 2022), and the intratumor tumor microenvironment (TME) and the molecular events involved in this form remain elusive.